Efficacy and safety assessment of traditional Chinese medicine for erectile dysfunction: A meta-analysis and trial sequential analysis

被引:8
作者
Wu, Haoran [1 ]
Gao, Zezheng [2 ]
Dai, Dan [3 ]
Liu, Xing [1 ]
Fang, Yini [1 ]
Chen, Xuemei [1 ]
Wang, Qi [1 ]
机构
[1] Beijing Univ Chinese Med, Natl Inst Tradit Chinese Med Constitut & Prevent M, Beijing, Peoples R China
[2] China Acad Chinese Med Sci, Guanganmen Hosp, Inst Metab Dis, Beijing, Peoples R China
[3] China Acad Chinese Med Sci, Guanganmen Hosp, Dept Dermatol, Beijing, Peoples R China
关键词
erectile dysfunction; IIEF-5; meta-analysis; traditional Chinese medicine; trial sequential analysis; METABOLIC SYNDROME; MEN; PREVALENCE; RISK; TESTOSTERONE; ASSOCIATION; MANAGEMENT; INHIBITORS; SEVERITY; REASONS;
D O I
10.1111/andr.13420
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
BackgroundSeveral patients with erectile dysfunction do not accept or benefit from conventional therapy with phosphodiesterase type 5 inhibitors; thus, alternative and complementary therapies are in need. Traditional Chinese medicine has been treating erectile dysfunction in China, but its clinical value is inconclusive. ObjectiveTo systematically evaluate the efficacy and safety of traditional Chinese medicine in treating erectile dysfunction. MethodsRandomized controlled trials were retrieved from a comprehensive search in the literature published in the past decade from the Web of Science, PubMed, Embase, Cochrane Library, SinoMed, China National Knowledge Internet, WanFang, and VIP. We performed a meta-analysis of the International Index of Erectile Function 5 questionnaire scores, clinical recovery rates, and testosterone levels using Review Manager 5.4 software. The trial sequential analysis was conducted to check the results. ResultsA total of 45 trials with 5016 patients were included. Meta-analysis results showed that traditional Chinese medicine effectively improved the International Index of Erectile Function 5 questionnaire scores (weighted mean difference = 3.78, 95% confidence interval: 3.12, 4.44; p < 0.001), clinical recovery rates (risk ratio = 1.57, 95% confidence interval: 1.38, 1.79; p < 0.001), testosterone levels (weighted mean difference = 2.42, 95% confidence interval: 1.59, 3.25; p < 0.001) compared with the controls. The single and add-on applications of traditional Chinese medicine could improve the International Index of Erectile Function 5 questionnaire score (p < 0.001). The trial sequential analysis confirmed the robustness of the analysis of the International Index of Erectile Function 5 questionnaire scores. A significant difference in the incidence of adverse effects between the treatment and control groups was not observed (risk ratio = 0.82, 95% confidence interval: 0.65, 1.05; p = 0.12). ConclusionTraditional Chinese medicine can gain better responses in improving the International Index of Erectile Function 5 questionnaire scores, clinical recovery rates, and testosterone levels as an alternative and complementary treatment, with no increase in side effects. However, more standardized, long-term, traditional Chinese medicine and integrative therapy clinical trials are needed to support the clinical application of traditional Chinese medicine.
引用
收藏
页码:1345 / 1367
页数:23
相关论文
共 104 条
[1]  
Ailiyasi A, 2019, J HUNAN U CHIN MED, V39, P644, DOI [10.3969/j.issn.1674-070X.2019.05.019, DOI 10.3969/J.ISSN.1674-070X.2019.05.019]
[2]  
[Anonymous], 2020, REV MAN REVMAN PROGR
[3]  
[Anonymous], 2021, TRIAL SEQ AN TSA PRO
[4]  
[Anonymous], 2016, ZHONGHUA NAN KE XUE
[5]   Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial [J].
Bajaj, Harpreet S. ;
Gerstein, Hertzel C. ;
Rao-Melacini, Purnima ;
Basile, Jan ;
Colhoun, Helen ;
Conget, Ignacio ;
Cushman, William C. ;
Dagenais, Gilles R. ;
Franek, Edward ;
Hanefeld, Markolf ;
Keltai, Matyas ;
Lakshmanan, Mark ;
Lanas, Fernando ;
Leiter, Lawrence A. ;
Lopez-Jaramillo, Patricio ;
Pirags, Valdis ;
Pogosova, Nana ;
Probstfield, Jeffrey ;
Raubenheimer, Peter ;
Ryden, Lars ;
Shaw, Jonathan E. ;
Sheu, Wayne H-H ;
Xavier, Denis .
LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (08) :484-490
[6]   Testosterone replacement therapy [J].
Barbonetti, Arcangelo ;
D'Andrea, Settimio ;
Francavilla, Sandro .
ANDROLOGY, 2020, 8 (06) :1551-1566
[7]   The Relationship Between Metabolic Syndrome, Its Components, and Erectile Dysfunction: A Systematic Review and a Meta-Analysis of Observational Studies [J].
Besiroglu, Huseyin ;
Otunctemur, Alper ;
Ozbek, Emin .
JOURNAL OF SEXUAL MEDICINE, 2015, 12 (06) :1309-1318
[8]   Erectile Dysfunction: AUA Guideline [J].
Burnett, Arthur L. ;
Nehra, Ajay ;
Breau, Rodney H. ;
Culkin, Daniel J. ;
Faraday, Martha M. ;
Hakim, Lawrence S. ;
Heidelbaugh, Joel ;
Khera, Mohit ;
McVary, Kevin T. ;
Miner, Martin M. ;
Nelson, Christian J. ;
Sadeghi-Nejad, Hossein ;
Seftel, Allen D. ;
Shindel, Alan W. .
JOURNAL OF UROLOGY, 2018, 200 (03) :633-641
[9]   Lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction: from physiology to clinical aspects [J].
Calogero, Aldo E. ;
Burgio, Giovanni ;
Condorelli, Rosita A. ;
Cannarella, Rossella ;
La Vignera, Sandro .
AGING MALE, 2018, 21 (04) :261-271
[10]   Dropout in the Treatment of Erectile Dysfunction with PDE5: A Study on Predictors and a Qualitative Analysis of Reasons for Discontinuation [J].
Carvalheira, Ana A. ;
Pereira, Nuno Monteiro ;
Maroco, Joao ;
Forjaz, Vera .
JOURNAL OF SEXUAL MEDICINE, 2012, 9 (09) :2361-2369